Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
94546 trials found · Page 134 of 4728
-
Can induced cooling save more brains after In-Hospital cardiac arrest?
Disease control Not yet recruitingThe IH-TTM trial is designed to determine whether survival with a favorable neurological outcome is improved by induced hypothermia at 33°C in comatose critically ill patients admitted after resuscitated in-hospital cardiac arrest (IHCA). Recent evidence suggests that targeted te…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 15, 2026 11:13 UTC
-
New mRNA shingles vaccine enters phase 2 trial
⭐️ VACCINE ⭐️ Not yet recruitingThe study will evaluate the safety, tolerability, and immunogenicity (your immune system's reaction) of 3 dose levels of the study vaccine called Herpes Zoster IN001 mRNA Vaccine (IN001) in healthy participants who are between 50 and 79 years of age.
Phase: PHASE2 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:02 UTC
-
Fat infusion showdown: can a better oil save preemie lungs and brains?
Disease control Recruiting nowThe purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE …
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New combo therapy aims to tame leukemia without lifelong pills
Disease control Not yet recruitingThe goal of this clinical research study is to find out if treatment with a combination of dasatinib plus ropeginterferon can help to control CML-CP. The safety of this combination will also be studied.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Engineered immune cells take on hard-to-treat cancers in early trial
Disease control Not yet recruitingOnly enrolling in Canada. The purpose of this study is to identify the highest dose of GCAR1, a chimeric antigen receptor (CAR-T) cell therapy, that can be tolerated without causing very severe side effects, and to see what effects GCAR1 has on selected cancers
Phase: PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
New hope for aggressive brain tumors: experimental combo targets first recurrence
Disease control Not yet recruitingApproximately 58-68 total subjects will be enrolled. In the first stage, 10 response evaluable subjects (either IDHwt or IDHm Grade 4 astrocytoma) will be enrolled. If 1 or more of the first 10 response evaluable subjects achieve an objective response, 19 further subjects may be …
Phase: PHASE1, PHASE2 • Sponsor: Starlight Therapeutics Inc. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
New hope for brain metastases: drug combo targets tumors in the brain
Disease control Not yet recruitingBrain metastasis represents one of the worst prognostic outcomes in advanced malignant tumors. Approximately 10% to 40% of patients with solid tumors develop brain metastases, a incidence rate significantly higher than that of primary malignant brain tumors. Over 80% of patients …
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Smart bug test aims to stop deadly pneumonia in ventilated ICU patients
Prevention Not yet recruitingVentilator-associated pneumonia (VAP) remains the most common hospital-acquired infection worldwide, affecting up to 40% of mechanically ventilated patients and contributing to increased morbidity, prolonged hospital stays, and high mortality rates. Standard prevention strategies…
Phase: PHASE2 • Sponsor: University of Calgary • Aim: Prevention
Last updated May 12, 2026 13:42 UTC
-
New hope for leukemia patients: targeted drug combo after transplant
Disease control Recruiting nowThe study population consisted of FLT3-ITD-mutated AML patients who were FLT3-ITD-positive before allogeneic hematopoietic stem cell transplantation. This open-label, randomized, controlled trial enrolled participants and randomly assigned them in a 1:1 ratio to either the experi…
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
New combo aims to fight lung cancer that outsmarted earlier drugs
Disease control Not yet recruitingThis single-center, prospective study and aims to evaluate the efficacy and safety of limertinib combined with etoposide and carboplatin in EGFR-mutant NSCLC patients who develop small-cell lung cancer transformation following progression on EGFR-TKI therapy.
Phase: PHASE2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
New hope for advanced colon cancer: combo therapy enters trial
Disease control Not yet recruitingThis is a randomized, parallel, open-label, multicenter exploratory clinical study designed to investigate the efficacy and safety of iparomlimab and tuvonralimab in combination with fruquintinib plus heterogeneous radiotherapy, compared with fruquintinib monotherapy, as the thir…
Phase: PHASE2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Phone app aims to bring HIV prevention to hidden transgender community
Prevention Not yet recruitingThe prevalence of HIV (Human Immunodeficiency Virus) and STIs (Sexually Transmitted Infections) is very high in the trans population, due to multifactorial components. The main risk factors for HIV in this population are unprotected receptive and insertive anal intercourse, mult…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated May 11, 2026 20:39 UTC
-
Smart scans guide tailored chemo for HER2+ breast cancer
Disease control Not yet recruitingThis study evaluates HER2-PET/CT-guided dynamic optimization of neoadjuvant therapy in patients with early-stage HER2-positive breast cancer. Based on metabolic response after two cycles, patients receive either intenstified treatment (Arm A) or de-escalation treatment (Arm B), a…
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Promising new combo aims to shrink penile cancer before surgery
Disease control Not yet recruitingThis clinical study is a Phase II research trial focused on a new preoperative treatment for men with advanced penile squamous cell carcinoma (a type of penile cancer). The cancer may be hard to treat with penile-sparing surgery, or it may have spread to nearby lymph nodes (like …
Phase: PHASE2 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Gene therapy hope for rare AGU disease enters human trials
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the treatment is a safe, tolerable, and efficacious treatment for adults and children with Aspartylglucosaminuria (AGU).
Phase: PHASE1, PHASE2 • Sponsor: Rare Trait Hope • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Nasal spray may ward off Post-Surgery confusion in seniors
Symptom relief Not yet recruitingThis study aims to determine whether, compared with placebo, the nighttime self-administration of a nasal dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in high-risk patients.
Phase: PHASE2, PHASE3 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Symptom relief
Last updated May 15, 2026 11:25 UTC
-
New combo therapy aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThe purpose of this randomized Phase II study is to evaluate and compare the efficacy and safety of neoadjuvant radio-immunotherapy versus immunotherapy alone for patients with locally advanced head and neck squamous cell carcinoma (HNSCC). Participants will be randomly assigned …
Phase: PHASE2 • Sponsor: Chen Chunyan • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Every second counts: can Pocket-Sized defibrillators double cardiac arrest survival?
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to learn the feasibility of equipping the volunteer community responders (VCR) with the mobile external automated defibrillators (mAEDs) for the management of adults experiencing out-of-hospital cardiac arrest (OHCA) patients. It will also provi…
Phase: NA • Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC
-
AI eye on stomach cancer: new model aims to catch it early
Diagnosis Recruiting nowEarly gastric cancer (EGC) is often difficult to detect accurately during endoscopic examination due to subtle morphological features and variability among endoscopists. Artificial intelligence (AI) has shown promise in improving diagnostic performance; however, most existing mod…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Diagnosis
Last updated May 15, 2026 11:14 UTC
-
Triple therapy aims to turn inoperable lung cancer into a surgical target
Disease control Not yet recruitingThe goal of this phase 2 trial is to evaluate the efficacy and safety of tislelizumab combined with intravenous chemotherapy and bronchial artery chemoembolization (BACE) as conversion therapy for patients with initially unresectable stage IIIA-IIIB non-small cell lung cancer (NS…
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated May 13, 2026 16:03 UTC